Crown Advisors Management’s AYTU BioPharma AYTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$428K Hold
200,000
– – 0.3% 42
2026
Q2
$430K Buy
200,000
+55,000
+38% +$130K 0.24% 42
2026
Q1
$395K Buy
+145,000
New +$371K 0.26% 38

Other funds holding AYTU

Crown Advisors Management's AYTU Position: Q3 2026 in Review

Crown Advisors Management held its AYTU BioPharma (AYTU) position steady in Q3 2026 at 200,000 shares worth $428K. The position accounts for 0.3% of the portfolio, ranked #42.

Crown Advisors Management first reported a position in AYTU in Q1 2026 and has held it in 3 quarters since. The position peaked at $430K in Q2 2026. 36 funds tracked by Wall St. Rank hold AYTU as of Q3 2026.

  • Crown Advisors Management held 200,000 shares of AYTU BioPharma worth $428K as of Q3 2026.
  • Crown Advisors Management left its AYTU BioPharma share count unchanged in Q3 2026.
  • AYTU BioPharma made up 0.3% of Crown Advisors Management's portfolio in Q3 2026, its #42 holding.
  • Crown Advisors Management first reported a position in AYTU BioPharma in Q1 2026 and has held it in 3 quarters since.
  • Crown Advisors Management's AYTU BioPharma position peaked at $430K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2026.

Based on Crown Advisors Management's 13F filing for Q3 2026, filed 12 Nov 2026.